Immune Globulin (IG) Feature Articles

The experts at Nufactor, along with our guest experts, continuously develop informative and timely articles related to diseases treated with Immune Globulin, as well as helpful advice and clinical briefs relevant to patients receiving IG therapy. Please check back often as new articles are released:

IVIG for Small Fiber Neuropathy
By Michelle Greer, RN, Senior Vice President - Sales, Nufactor,
February 2018

Managing and Treating Myositis-Related Interstitial Lung Disease
By Michelle Greer, RN, Senior Vice President - Sales, Nufactor,
January 2017

Treating MS with IVIG Therapy
By Michelle Greer, RN, Senior Vice President - Sales, Nufactor,
November 2016

Treating Complications of CLL with IVIG Therapy
By Michelle Greer, RN, Senior Vice President - Sales, Nufactor,
and Emilee A. Thomas, MPH, PA-C, CLL Research Center New York
September 2016

Immune Globulin Therapies: Comparing Routes of Administration
By Michelle Greer, RN, Senior Vice President - Sales, Nufactor,
May 2016

Subcutaneous Immune Globulin Therapy for Neuromuscular Disease
By Michelle Greer, RN, Senior Vice President - Sales, Nufactor,
January 2016

Transitioning IG Coverage to Medicare
By Michelle Greer, RN, and Leslie Vaughan, RPh
October 2015

The Current Role of Hematopoietic Stem Cell Transplant in Primary Immunodeficiency Diseases
By Michelle Greer, RN
October 2015

Reducing SCIG Side Effects
By Michelle Greer, RN, Senior Vice President - Sales, Nufactor
September 2015

Nufactor Announces IG Nursing Notes Blog
Nufactor
April 2015

Overcoming SCIG Needle Anxiety
By Amy Ehlers, BS, PharmD, BCPS, Nufactor
April 2013

Immune Globulin: A Guide to Billing and Reimbursement
By Ronale Tucker Rhodes, MS, Leslie Vaughan, RPh, and Michelle Greer, RN
February 2013

A Long-Term Effects of PIDDs
By Annaben Kazemi
January 2013

When It Turns Out to Be Primary Immunodeficiency Disease: Benefits of Early Diagnosis
By Keith Berman, MPH, MBA
January 2013

Diagnosing and Treating Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
By Michelle Greer, RN, Senior Vice President - Sales, Nufactor, and
Gil I. Wolfe, MD, FAAN
November 2012

Diagnosing and Treating Peripheral Neuropathy
By Todd Levine, MD
June 2012

Individual IG Dosing Strategies
By Ronale Tucker Rhodes, MS, and Kris McFalls
January 2012

Grifols Expands PatientCare Program
August 2011

Study Helps to Explain IG Distribution in the Body
By IG Living Magazine
June 2011

Florida Adds SCID to Newborn Screening Panel
By IG Living Magazine
April 2011

An Overview of Immune Globulin Dosing
By Kris McFalls
February 2011

FDA Approves Grifols' Flebogamma DIF 10% IVIG
January 2011

On- and Off-Label Uses and Clinical Trials of IG
By Ronale Tucker Rhodes, MS, and Kris McFalls
December 2010

Understanding and Treating IG Side Effects
By Ronale Tucker Rhodes, MS, and Kris McFalls
April 2010

A Comparative Look at IVIG and SCIG
By Ronale Tucker Rhodes, MS, and Kris McFalls

IVIG: At the Intersection of Immunology and Clinical Research
By Keith Berman, MPH, MBA